FDA Adverse Event Malfunction Summary report: N

BINAXNOW COVID-19 AG SELF TEST 2CT

MDR report key: 23221996 · Received October 6, 2025

Report

Report Number
1221359-2025-00417
Event Type
Malfunction
Date Received
October 6, 2025
Date of Event
September 15, 2025
Report Date
December 4, 2025
Manufacturer
ABBOTT DIAGNOSTICS SCARBOROUGH, INC.
Product Code
QYT
PMA / PMN Number
K243518
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
003

Narratives

Additional Manufacturer Narrative · 0

THE INVESTIGATION REMAINS IN PROGRESS. A SUPPLEMENTAL REPORT WILL BE PROVIDED AFTER COMPLETION.

Additional Manufacturer Narrative · 0

CORRECTION: H6 - TYPE OF INVESTIGATION CODES. INVESTIGATION SUMMARY: THE REQUIRED INFORMATION TO ENABLE FURTHER INVESTIGATION, SUCH AS THE KIT'S LOT NUMBER, WAS NOT PROVIDED AND AN INVESTIGATION WAS NOT ABLE TO BE PERFORMED. A PRODUCT DEFICIENCY COULD NOT BE DETERMINED. NOTWITHSTANDING, COMPLAINTS AGAINST THESE TREND CODES ARE MONITORED TO IDENTIFY AND TRACK ANY OUT-OF-TREND/UNEXPECTED PERFORMANCE AT THE LOT AND PRODUCT FAMILY LEVEL. IN CONCLUSION, ABBOTT DIAGNOSTICS SCARBOROUGH WAS UNABLE TO DETERMINE THE EXACT ROOT CAUSE OF THE REPORTED ISSUES AS NO INFORMATION WAS PROVIDED FOR INVESTIGATION.

Additional Manufacturer Narrative · 0

INVESTIGATION SUMMARY: THE REQUIRED INFORMATION TO ENABLE FURTHER INVESTIGATION, SUCH AS THE KIT'S LOT NUMBER, WAS NOT PROVIDED AND AN INVESTIGATION WAS NOT ABLE TO BE PERFORMED. A PRODUCT DEFICIENCY COULD NOT BE DETERMINED. NOTWITHSTANDING, COMPLAINTS AGAINST THESE TREND CODES ARE MONITORED TO IDENTIFY AND TRACK ANY OUT-OF-TREND/UNEXPECTED PERFORMANCE AT THE LOT AND PRODUCT FAMILY LEVEL. IN CONCLUSION, ABBOTT DIAGNOSTICS SCARBOROUGH WAS UNABLE TO DETERMINE THE EXACT ROOT CAUSE OF THE REPORTED ISSUES AS NO INFORMATION WAS PROVIDED FOR INVESTIGATION.

Description of Event or Problem · 0

THE CONSUMER REPORTED FALSE NEGATIVE WITH THE BINAXNOW COVID-19 ANTIGEN SELF-TEST PERFORMED ON (B)(6) 2025 WITH A NASAL SAMPLE. CONFIRMATION TESTING WAS PERFORMED AND GENERATED A POSITIVE RESULT. THE CONSUMER STATED THAT THEY WERE SYMPTOMATIC. ALTHOUGH REQUESTED, NO ADDITIONAL INFORMATION INCLUDING PATIENT TREATMENT AND OUTCOME WAS PROVIDED.

Description of Event or Problem · 0

THE CONSUMER REPORTED A FALSE NEGATIVE WITH THE BINAXNOW COVID-19 ANTIGEN SELF-TEST PERFORMED ON (B)(6) 2025 WITH A NASAL SAMPLE. THE CONSUMER VISITED AN URGENT CARE FACILITY ON (B)(6) 2025 WHERE CONFIRMATION TESTING (PLATFORM UNKNOWN) WAS PERFORMED AND GENERATED A POSITIVE RESULT. THE CONSUMER STATED THAT THEY WERE SYMPTOMATIC. ALTHOUGH REQUESTED, NO ADDITIONAL INFORMATION INCLUDING PATIENT TREATMENT AND OUTCOME WAS PROVIDED.

Description of Event or Problem · 0

THE CONSUMER REPORTED A FALSE NEGATIVE WITH THE BINAXNOW COVID-19 ANTIGEN SELF-TEST PERFORMED ON (B)(6) 2025 WITH A NASAL SAMPLE. THE CONSUMER VISITED AN URGENT CARE FACILITY ON (B)(6) 2025 WHERE CONFIRMATION TESTING (PLATFORM UNKNOWN) WAS PERFORMED AND GENERATED A POSITIVE RESULT. THE CONSUMER STATED THAT THEY WERE SYMPTOMATIC. ALTHOUGH REQUESTED, NO ADDITIONAL INFORMATION INCLUDING PATIENT TREATMENT AND OUTCOME WAS PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2309424 BINAXNOW COVID-19 AG SELF TEST 2CT CORONAVIRUS ANTIGEN DETECTION TEST SYSTEM. QYT ABBOTT DIAGNOSTICS SCARBOROUGH, INC.

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown